Related Experiment Videos
Prospective randomized comparative study of tracheoesophageal voice prosthesis: Blom-Singer versus Provox
K Delsupehe1, I Zink, M Lejaegere
1Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, St Rafaël Hospital, Belgium.
The Laryngoscope
|October 20, 1998
Summary
Blom-Singer and Provox tracheoesophageal voice prostheses offer similar voice quality and patient satisfaction. Factors like cost and patient preference should guide prosthesis selection.
Area of Science:
- Laryngology
- Speech-Language Pathology
- Prosthodontics
Background:
- Tracheoesophageal voice prostheses are crucial for voice restoration after laryngectomy.
- Blom-Singer and Provox devices are widely used but require comparative analysis.
Purpose of the Study:
- To compare the voice quality, prosthesis longevity, and patient satisfaction between Blom-Singer and Provox tracheoesophageal voice prostheses.
- To analyze objective and subjective voice parameters and identify factors influencing outcomes.
Main Methods:
- A prospective study involving 52 patients and 113 tracheoesophageal voice prostheses (Blom-Singer and Provox).
- Voice recordings were analyzed objectively and subjectively at 1 and 4 months post-placement.
- Patient satisfaction and prosthesis survival were assessed, with subgroup analyses for placement type and surgical extent.
Main Results:
- Both Blom-Singer and Provox prostheses demonstrated comparable voice quality, longevity, and patient satisfaction.
- Provox showed slightly better cleaning management, while Blom-Singer trended towards superior voice quality.
- Secondary placements and total laryngectomies yielded better voice outcomes.
Conclusions:
- Blom-Singer and Provox prostheses provide effective voice restoration with similar outcomes.
- Clinical decisions should consider patient-specific factors like cost, maintenance, and individual preference alongside performance.
- Further research may explore long-term functional differences and patient-reported quality of life.